CreatorsPublishersAdvertisers
View more in
Rockville, MD

AbbVie makes another gene therapy move, paying $370M to partner with Regenxbio

MedCity News
 2021-09-13

Cover picture for the articleAbbVie has been looking for ways to diversify its product lineup, and its latest move expands its gene therapy prospects through a partnership with Regenxbio on its lead product candidate in development for treating two eye diseases. Under an agreement announced Monday, AbbVie is paying Regenxbio $370 million up...

medcitynews.com

Comments / 0

Comments / 0